These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 15142370)

  • 1. The RET IVS1-126G>T variant is strongly associated with the development of sporadic medullary thyroid cancer.
    Fernandez RM; Robledo M; Antinolo G; Pecina A; Ruiz-Llorente S; Eng C; Borrego S
    Thyroid; 2004 Apr; 14(4):329-31. PubMed ID: 15142370
    [No Abstract]   [Full Text] [Related]  

  • 2. The familial medullary thyroid carcinoma-associated RET E768D mutation in a multiple endocrine neoplasia type 2A case.
    Aiello A; Cioni K; Gobbo M; Collini P; Gullo M; Della Torre G; Passerini E; Ferrando B; Pilotti S; Pierotti MA; Pasini B
    Surgery; 2005 May; 137(5):574-6. PubMed ID: 15855933
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medullary cancers of the thyroid: genetic aspects].
    Orgiazzi J
    Ann Endocrinol (Paris); 2003 Oct; 64(4):345-9. PubMed ID: 14595251
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multiple endocrine neoplasia 2A type: a genetic study of one family].
    Arias Miranda IM; Casal Alvarez F; Castaño L
    Med Clin (Barc); 2005 Jan; 124(3):116. PubMed ID: 15710101
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma.
    Magalhães PK; de Castro M; Elias LL; Soares EG; Maciel LM
    Thyroid; 2004 Oct; 14(10):848-52. PubMed ID: 15588382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan.
    Kameyama K; Okinaga H; Takami H
    Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma.
    Huang SC; Torres-Cruz J; Pack SD; Koch CA; Vortmeyer AO; Mannan P; Lubensky IA; Gagel RF; Zhuang Z
    J Clin Endocrinol Metab; 2003 Jan; 88(1):459-63. PubMed ID: 12519890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)].
    Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H
    Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of patients with hereditary medullary thyroid carcinoma.
    Fitze G
    Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients.
    Lesueur F; Cebrian A; Cranston A; Leyland J; Faid TM; Clements MR; Robledo M; Whittaker J; Ponder BA
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3454-7. PubMed ID: 15741265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A.
    Chung YJ; Kim HH; Kim HJ; Min YK; Lee MS; Lee MK; Kim KW; Ki CS; Kim JW; Chung JH
    Thyroid; 2004 Oct; 14(10):813-8. PubMed ID: 15588376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline RET V804M mutation associated with multiple endocrine neoplasia type 2A.
    Gibelin H; Bezieau S; Misso C; Bouin-Pineau MH; Maréchaud R; Kraimps JL
    Br J Surg; 2004 Nov; 91(11):1458-9. PubMed ID: 15386323
    [No Abstract]   [Full Text] [Related]  

  • 13. [RET mutations and preventive treatment of medullary thyroid cancer].
    Niccoli-Sire P; Conte-Devolx B;
    Ann Endocrinol (Paris); 2005 Jun; 66(3):168-75. PubMed ID: 15988377
    [No Abstract]   [Full Text] [Related]  

  • 14. Description of the first two seemingly unrelated Greek Cypriot families with a common C618R RET proto-oncogene mutation.
    Neocleous V; Passalaris T; Spanou E; Kitsios P; Skordis N; Deltas CC
    Genet Test; 2004; 8(2):163-8. PubMed ID: 15345114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2).
    Jimenez C; Gagel RF
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S150-7. PubMed ID: 15135800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations of familial medullary thyroid carcinoma.
    Kameyama K; Okinaga H; Takami H
    Biomed Pharmacother; 2004; 58(6-7):348-50. PubMed ID: 15271414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.
    Arighi E; Popsueva A; Degl'Innocenti D; Borrello MG; Carniti C; Perälä NM; Pierotti MA; Sariola H
    Mol Endocrinol; 2004 Apr; 18(4):1004-17. PubMed ID: 14715928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.
    McWhinney SR; Boru G; Binkley PK; Peczkowska M; Januszewicz AA; Neumann HP; Eng C
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4911-6. PubMed ID: 14557473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A RET C634R mutation in a Thai female with multiple endocrine neoplasia type 2A.
    Sunthornyothin S; Sinthuwiwat T; Shotelersuk V
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S472-6. PubMed ID: 12930027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual vignette. Multiple endocrine neoplasia type 2A (MEN2A) associated with cutaneous lichen amyloidosis.
    Bonbassei GJ
    Endocr Pract; 2003; 9(6):570. PubMed ID: 14758805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.